Patents by Inventor Gilles Marchal

Gilles Marchal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8414865
    Abstract: Use of Mycobacterium bovis BCG killed by Extended Freeze Drying (EFD) for preventing or treating atherosclerosis.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: April 9, 2013
    Assignees: Institut Pasteur, Institut National de la Recherche Agronomique
    Inventors: Gilles Marchal, Micheline Lagranderie, Isabelle Schwartz-Cornil
  • Patent number: 8404250
    Abstract: This application relates to compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intracellular bacteria for treatment of disorders comprising an immune dysregulation in humans and animals.
    Type: Grant
    Filed: October 21, 2009
    Date of Patent: March 26, 2013
    Assignees: Institut Pasteur, Institut National de la Sante et de la Recherche Medicale
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernardo Boris Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre
  • Publication number: 20120201856
    Abstract: Use of Mycobacterium bovis BCG killed by Extended Freeze Drying (EFD) for preventing or treating atherosclerosis.
    Type: Application
    Filed: August 12, 2010
    Publication date: August 9, 2012
    Applicant: BIOMET MANUFACTURING CORP.
    Inventors: Gilles Marchal, Micheline Lagranderie, Isabelle Schwartz-Cornil
  • Publication number: 20120156169
    Abstract: The invention relates to a recombinant vector comprising a mycobacterial FAP protein coding sequence under the transcriptional control of a promoter active under hypoxia conditions and its use for the prevention and the treatment of epithelial tumors.
    Type: Application
    Filed: December 13, 2011
    Publication date: June 21, 2012
    Applicant: Institut Pasteur
    Inventors: Gilles MARCHAL, Mohammad Abolhassani
  • Publication number: 20110033567
    Abstract: Preparation comprising Mycobacterium bovis BCG killed by Extended Freeze Drying (EFD) for preventing and/or treating rheumatoid arthritis.
    Type: Application
    Filed: February 6, 2009
    Publication date: February 10, 2011
    Inventors: Gilles Marchal, Micheline Lagranderie, Marie-Christophe Boissier, Natacha Bessis
  • Patent number: 7871627
    Abstract: Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intra-cellular bacteria, for example mycobacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as cancer, autoimmune diseases, allergy and tuberculosis.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: January 18, 2011
    Assignees: Institut Pasteur, Institut National de la Sante Et de la Recherche Medicale (INSERM)
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernardo Boris Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre
  • Publication number: 20100272756
    Abstract: This application relates to compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intracellular bacteria for treatment of disorders comprising an immune dysregulation in humans and animals.
    Type: Application
    Filed: October 21, 2009
    Publication date: October 28, 2010
    Applicants: INSTITUT PASTEUR, INSTITUT NAT DE LA SANTE ET DE LA RECHERCHE MED
    Inventors: Marie-Anne NAHORI, Micheline Lagranderie, Gilles Marchal, Bernardo Boris Vargaftig, Jean Lefort, Félix Romain, Georges Hekimian, Philippe Peltre
  • Patent number: 7820142
    Abstract: The invention relates to immunogenic glycopeptides derived from pathogenic microorganisms, which can be used for immunization and diagnosing infections dye to such pathogenic microorganisms and also to method for the selection and preparation thereof.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: October 26, 2010
    Assignee: Institut Pasteur
    Inventors: Gilles Marchal, Félix Romain, Pascale Pescher, Françoise Baleux, Daniel Scott-Algara, Laurence Mulard
  • Patent number: 7658929
    Abstract: The invention concerns immunogenic glycopeptides derived from pathogenic microorganisms, useful for vaccination and diagnosis of infections caused by said pathogenic microorganisms (bacteria or fungi), and methods for selecting them and preparing them.
    Type: Grant
    Filed: February 21, 2008
    Date of Patent: February 9, 2010
    Assignee: Institut Pasteur
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher
  • Publication number: 20090304637
    Abstract: The invention relates to a recombinant vector comprising a mycobacterial FAP protein coding sequence under the transcriptional control of a promoter active under hypoxia conditions and its use for the prevention and the treatment of epithelial tumors.
    Type: Application
    Filed: July 25, 2007
    Publication date: December 10, 2009
    Applicant: INSTITUT PASTEUR
    Inventors: Gilles Marchal, Mohammad Abolhassani
  • Publication number: 20090280146
    Abstract: This invention relates to the use of a preparation of killed or non infectious Gram positive bacteria such as Gram positive facultative intracellular bacteria, for example mycobacteria, for the treatment of intestinal inflammatory syndromes such as Crohn's disease or ulcerative colitis.
    Type: Application
    Filed: December 21, 2006
    Publication date: November 12, 2009
    Applicants: INSTITUT PASTEUR, YISSUM RESEARCH DEVELOPMENT COMPANY
    Inventors: Gilles Marchal, Micheline Lagranderie, Mohammad Abolhassani, Herve Bercovier
  • Publication number: 20080293620
    Abstract: A method for diagnosing an infection in a patient likely to be infected with a pathogenic microorganism, comprising the detection of CD4+ T lymphocytes recognizing at least one glycopeptide derived from said pathogenic microorganism, essentially consisting of a glycosylated T epitope, comprising from 14 to 25 amino acids, among which at least one neutral amino acid is bonded to a disaccharide or to a trisaccharide, and at least 15% of said amino acids are prolines, one of the prolines being located in position ?1 to ?4, relative to the position of said neutral amino acid.
    Type: Application
    Filed: September 29, 2005
    Publication date: November 27, 2008
    Applicant: Institut Pasteur
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher, Francoise Baleux, Daniel Scott-Algara, Laurence Mulard
  • Publication number: 20080233599
    Abstract: The invention concerns immunogenic glycopeptides derived from pathogenic microorganisms, useful for vaccination and diagnosis of infections caused by said pathogenic microorganisms (bacteria or fungi), and methods for selecting them and preparing them.
    Type: Application
    Filed: February 21, 2008
    Publication date: September 25, 2008
    Applicant: INSTITUT PASTEUR
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher
  • Patent number: 7361348
    Abstract: The invention concerns immunogenic glycopeptides derived from pathogenic microorganisms, useful for vaccination and diagnosis of infections caused by said pathogenic microorganisms (bacteria or fungi), and methods for selecting them and preparing them.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: April 22, 2008
    Assignee: Institut Pasteur
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher
  • Publication number: 20070190076
    Abstract: Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intra-cellular bacteria, for example mycobacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as cancer, autoimmune diseases, allergy and tuberculosis.
    Type: Application
    Filed: November 17, 2006
    Publication date: August 16, 2007
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernado Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre
  • Patent number: 7101555
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28 779 Da, and hybrid proteins containing at least portions of its sequence. These proteins may in particular be used in vaccines or for the detection of specific tuberculosis antibodies.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: September 5, 2006
    Assignee: Institut Pasteur
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • Publication number: 20060067888
    Abstract: The invention relates to immunogenic glycopeptides derived from pathogenic microorganisms, which can be used for immunization and diagnosing infections dye to such pathogenic microorganisms and also to method for the selection and preparation thereof.
    Type: Application
    Filed: September 30, 2004
    Publication date: March 30, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher, Francoise Baleux, Daniel Scott-Algara, Laurence Mulard
  • Publication number: 20060062807
    Abstract: Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intra-cellular bacteria, for example mycobacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as cancer, autoimmune diseases, allergy and tuberculosis.
    Type: Application
    Filed: December 11, 2002
    Publication date: March 23, 2006
    Inventors: Marie-Anne Nahori, Micheline Lagranderie, Gilles Marchal, Bernado Vargaftig, Jean Lefort, Felix Romain, Georges Hekimian, Philippe Peltre
  • Publication number: 20040171523
    Abstract: The invention concerns immunogenic glycopeptides derived from pathogenic microorganisms, useful for vaccination and diagnosis of infections caused by said pathogenic microorganisms (bacteria or fungi), and methods for selecting them and preparing them.
    Type: Application
    Filed: June 20, 2003
    Publication date: September 2, 2004
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher
  • Publication number: 20040142453
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28 779 Da, and hybrid proteins containing at least portions of its sequence.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 22, 2004
    Applicant: INSTITUT PASTEUR
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain